簡單說
2022供貨2000萬劑
2023供貨1500萬劑
這邊達成的協議是從2021買的500萬劑這張合約擴充的。
消息來源為：https://bwnews.pr/3zqgDdb
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (
mRNA) therapeutics and vaccines, today announced a new supply agreement with Tai
wan for 20 million doses of Moderna’s COVID-19 vaccine and its updated variant
booster vaccine candidate, if authorized, to begin delivery in 2022 and an addit
ional 15 million doses in 2023. This new supply agreement is in addition to the
prior agreement for 5 million doses in 2021.